Rosenblatt Michael
- SEC CIK
- 0001478797
No open-market purchases or sales filed in the past year.
Current role at each company
- AZTA Azenta, Inc.Directoras of Feb 13, 2024
- AXLA Axcella Health Inc.Directoras of May 23, 2022
- RUBY Rubius Therapeutics, Inc.Directoras of May 13, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Rosenblatt Michael as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
AZTA Azenta, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 15, 2021 (view filing) | Nov 12 | 3 days | Rosenblatt MichaelDirector | SSale | −2.83K | $114.13 | −$323.1K | −35.9%5.05K after |